FDA Clears Mobile Medical App to Help those with Opioid Use Disorder Stay in Recovery Programs
Today, the U.S. Food and Drug Administration cleared a mobile medical application (app) to help increase retention (the amount of time a patient participates) in an outpatient treatment program for individuals with opioid use disorder (OUD). The reSET-O app is a prescription cognitive behavioral therapy intended to be used in addition to outpatient treatment under the care of a health care professional,
Read more ...
German Accelerator Life Sciences (GALS) Alumni Company SpinDiag Closes € 3M Funding Round
German Accelerator Life Sciences Alumni company, SpinDiag, just announced the successful closing of 3 million Series A funding round. The Freiburg-based health tech startup addresses the challenge of patients introducing drug-resistant bacteria into hospitals. SpinDiag provides a rapid point-of-care screening system, SpinDiag one, to test high-risk patients for all relevant drug-resistances.
Read more ...
FDA Grants Breakthrough Device Designation to Artificial Intelligence Software for CTEPH Pattern Recognition from Bayer and MSD
Bayer announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Artificial Intelligence Software for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Pattern Recognition, which Bayer is currently developing jointly with MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA).
Read more ...
Syntropy to Unlock the Value of Scientific Data in Fight to End Cancer
Merck, a leading science and technology company, and software company Palantir Technologies, today announced their intent to form a joint venture under the brand name Syntropy. Syntropy is expected to empower scientists and research centers with a collaborative technology platform to advance cancer research, help drive scientific discovery, and improve human lives.
Read more ...
Australian Health Region Boosts Patient Safety with Patientrack Technology
Patients and clinicians will benefit from easy access to critical real-time patient information at the bedside after Australian population health services provider ACT Health signed a further contract with Patientrack's parent company Alcidion Group (ASX:ALC).
Read more ...
MSD is Looking for a Digital Health Solution to Empower Oncologists by Keeping them Updated in their Field
MSD Lebanon is looking for an external partner to co-create a digital solution that helps oncologists to stay updated with relevant clinical content about cancer. The solution should consider several channels (web, app, email newsletter, social media, etc) and adapt to the preferences to each user, so they are motivated to access the content regularly over time.
Read more ...
Diagnosing a Heart Attack at 10,000 Meters
A passenger suddenly has chest pain on board. The crew asks for a doctor; when present, this is not always a cardiologist. The pilot has to decide if a flight diversion is required or not. The dilemma: Despite having a doctor on board, crucial ECG information is missing. As more and more older people fly and the trend towards long-distance travel increases, medical emergencies on board become more common.
Read more ...
Today, the U.S. Food and Drug Administration cleared a mobile medical application (app) to help increase retention (the amount of time a patient participates) in an outpatient treatment program for individuals with opioid use disorder (OUD). The reSET-O app is a prescription cognitive behavioral therapy intended to be used in addition to outpatient treatment under the care of a health care professional, 
German Accelerator Life Sciences Alumni company, SpinDiag, just announced the successful closing of 3 million Series A funding round. The Freiburg-based health tech startup addresses the challenge of patients introducing drug-resistant bacteria into hospitals. SpinDiag provides a rapid point-of-care screening system, SpinDiag one, to test high-risk patients for all relevant drug-resistances. 
Bayer announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Artificial Intelligence Software for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Pattern Recognition, which Bayer is currently developing jointly with MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA). 
Merck, a leading science and technology company, and software company Palantir Technologies, today announced their intent to form a joint venture under the brand name Syntropy. Syntropy is expected to empower scientists and research centers with a collaborative technology platform to advance cancer research, help drive scientific discovery, and improve human lives. 
Patients and clinicians will benefit from easy access to critical real-time patient information at the bedside after Australian population health services provider ACT Health signed a further contract with Patientrack's parent company Alcidion Group (ASX:ALC). 
A passenger suddenly has chest pain on board. The crew asks for a doctor; when present, this is not always a cardiologist. The pilot has to decide if a flight diversion is required or not. The dilemma: Despite having a doctor on board, crucial ECG information is missing. As more and more older people fly and the trend towards long-distance travel increases, medical emergencies on board become more common.